Abstract
Background/Aims
Few studies have classified risk factors according to the onset time of bleeding after endoscopic submucosal dissection (post-ESD bleeding).
Methods
We studied 1767 consecutive lesions in patients who underwent ESD for early gastric cancer from December 2006 through June 2016. Patients who had a remnant stomach or who had undergone reconstruction with a gastric tube were excluded. Post-ESD bleeding was classified into acute bleeding (0–5 days after ESD) and delayed bleeding (6 or more days after ESD), and the risk factors for each type of bleeding were compared.
Results
Post-ESD bleeding occurred in 150 (8.5%) of 1767 lesions. Bleeding was acute in 129 lesions (7.3%) and delayed in 21 (1.2%). Acute post-ESD bleeding was frequently associated with lesions located in the distal stomach, expanded indications or non-indicated lesions, a specimen diameter of ≥40 mm, and antithrombotic therapy. Delayed post-ESD bleeding was often associated with lesions located in the proximal stomach, hemodialysis, and antithrombotic therapy. Among 334 lesions in patients who received antithrombotic therapy, post-ESD bleeding occurred in 47 lesions (14.1%). Independent risk factors for post-ESD bleeding were a specimen diameter of ≥40 mm and treatment with 2 or more antithrombotic agents.
Conclusions
Acute post-ESD bleeding and delayed post-ESD bleeding were associated with different clinical characteristics. Antithrombotic therapy is a risk factor for post-ESD bleeding in both the acute and delayed phases.
Similar content being viewed by others
References
Gotoda T, Yamamoto H, Soetikno RM (2006) Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol 41:929–942
Uedo N, Takeuchi Y, Yamada T, Ishihara R, Ogiyama H, Yamamoto S, Kato M, Tatsumi K, Masuda E, Tamai C, Yamamoto S, Higashino K, Iishi H, Tatsuta M (2007) Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. Am J Gastroenterol 102:1610–1616
Yang Z, Wu Q, Liu Z, Wu K, Fan D (2011) Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials. Digestion 84:315–320
Koh R, Hirasawa K, Yahara S, Oka H, Sugimori K, Morimoto M, Numata K, Kokawa A, Sasaki T, Nozawa A, Taguri M, Morita S, Maeda S, Tanaka K (2013) Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. Gastrointest Endosc 78:476–482
Ono S, Ono M, Nakagawa M, Shimizu Y, Kato M, Sakamoto N (2016) Delayed bleeding and hemorrhage of mucosal defects after gastric endoscopic dissection on second-look endoscopy. Gastric Cancer 19:561–567
Takeuchi T, Ota K, Harada S, Edogawa S, Kojima Y, Tokioka S, Umegaki E, Higuchi K (2013) The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection. BMC Gastroenterol 13:136
Na S, Ahn JY, Choi KD, Kim MY, Lee JH, Choi KS, Kim do H, Song HJ, Lee GH, Jung HY, Kim JH (2015) Delayed bleeding rate according to the forrest classiffication in second-look endoscopy after endoscopic submucosal dissection. Dig Dis Sci 60:3108–3117
Mochizuki S, Uedo N, Oda I, Kaneko K, Yamamoto Y, Yamashina T, Suzuki H, Kodashima S, Yano T, Yamamichi N, Goto O, Shimamoto T, Fujishiro M, Koike K, SAFE Trial Study Group (2015) Scheduled second-look endoscopy is not recommended after endoscopic submucosal dissection for gastric neoplasms (the SAFE trial):a multicenter prospective randomized controlled non-inferiority trial. Gut 64:397–405
Ohkuwa M, Hosokawa K, Boku N, Ohtu A, Tajiri H, Yoshida S (2001) New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy 33:221–226
Ono H, Hasuike N, Inui T, Takizawa K, Ikehara H, Yamaguchi Y, Otake Y, Matsubayashi H (2008) Usefulness of a novel electrosurgical knife, the insulation-tipped diathermic knife-2, for endoscopic submucosal dissection of early gastric cancer. Gastric Cancer 11:47–52
Heldwein W, Schreiner J, Pedrazzoli J et al (1989) Is the Forrest classification a useful tool for planning endoscopic therapy of bleeding peptic ulcers? Endoscopy 21:258–262
Kazuei O (2005) The management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastroenterol Endosc 47:2691–2695(In Japanese)
Lambert R, Lightdale CJ, Lambert R, Lightdale C, Niwa H, Tytgat GN, Fujita R (2003) The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon : November 30 to December 1, 2002. Gastrointest Endosc 58:3–43
Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma, 3rd English edition. Gastric Cancer 14:101–112
Okada K, Yamamoto Y, Kasuga A, Omae M, Kubota M, Hirasawa T, Ishiyama A, Chino A, Tsuchida T, Fujisaki J, Nakajima A, Hoshino E, Igarashi M (2011) Risk factors for delayed bleeding after endoscopic submucosal dissection for gastric neoplasm. Surg Endosc 25:98–107
Toyokawa T, Inaba T, Omote S, Okamoto A, Miyasaka R, Watanabe K, Izumikawa K, Horii J, Fujita I, Ishikawa S, Morikawa T, Murakami T, Tomoda J (2012) Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection for early gastric neoplasms: analysis of 1123 lesions. J Gastroenterol Hepatol 27:907–912
Nakamura M, Nishikawa J, Hamabe K, Nishimura J, Satake M, Goto A, Kiyotoki S, Saito M, Fukagawa Y, Shirai Y, Okamoto T, Sakaida I (2012) Risk factors for delayed bleeding from endoscopic submucosal dissection of gastric neoplasms. Scand J Gastroenterol 47:1108–1114
Tsuji Y, Ohata K, Ito T, Chiba H, Ohya T, Gunji T, Matsuhashi N (2010) Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions. World J Gastroenterol 16:2913–2917
Numata N, Oka S, Tanaka S, Higashiyama M, Sanomura Y, Yoshida S, Arihiro K, Chayama K (2013) Clinical outcomes of endoscopic submucosal dissection for early gastric cancer in patients with chronic kidney disease. J Gastroenterol Hepatol 28:1632–1637
Higashiyama M, Oka S, Tanaka S, Sanomura Y, Imagawa H, Shishido T, Yoshida S, Chayama K (2011) Risk factors for bleeding after endoscopic submucosal dissection of gastric epithelial neoplasm. Dig Endosc 23:290–295
Cheung J, Yu A, LaBossiere J, Zhu Q, Fedorak RN (2010) Peptic ulcer bleeding outcomes adversely affected by end-stage renal desease. Gastrointest Endosc 71:44–49
Matsumura T, Arai M, Maruoka D, Okimoto K, Minemura S, Ishigami H, Saito K, Nakagawa T, Katsuno T, Yokosuka O (2014) Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents. BMC Gastroenterol 14:172
Choi CW, Kim HW, Kang DH, Hong YM, Kim SJ, Park SB, Cho M, Kim DJ, Hong JB (2014) Clinical outcomes of second-look endoscopy after gastric endoscopic submucosal dissection: predictive factors with high risks of bleeding. Surg Endosc 28:2213–2220
Kakushima N, Yahagi N, Fujishiro M, Iguchi M, Oka M, Kobayashi K, Hashimoto T, Omata M (2004) The healing process of gastric artificial ulcers after endoscopic submucosal dissection. Dig Endosc 16:327–331
Kakushima N, Fujishiro M, Kodashima S, Kobayashi K, Tateishi A, Iguchi M, Imagawa A, Motoi T, Yahagi N, Omata M (2006) Histopathologic characteristics of gastric ulcers created by endoscopic submucosal dissection. Endoscopy 38:412–415
Goto O, Fujishiro M, Kodashima S, Minatsuki C, Niimi K, Ono S, Yamamichi N, Koike K (2011) Short-term healing process of artificial ulcers after gastric endoscopic submucosal dissection. Gut Liver 5:293–297
Elmunzer BJ, Young SD, Inadomi JM, Schoenfeld P, Laine L (2008) Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am J Gastroenterol 103:2625–2632
Kobayashi M, Takeuchi M, Hashimoto S, Mizuno K, Sato Y, Narisawa R, Aoyagi Y (2012) Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide. Dig Dis Sci 57:119–126
Brullet E, Campo R, Calvet X, Coroleu D, Rivero E, Simó Deu J (1996) Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. Gut 39:155–158
Kiyotoki S, Nishikawa J, Satake M, Fukagawa Y, Shirai Y, Hamabe K, Saito M, Okamoto T, Sakaida I (2010) Usefulness of magnifying endoscopy with narrow-band imaging for determining gastric tumor margin. J Gastroenterol Hepatol 25:1514–1517
Tano S, Horiki N, Omata F, Tanaka K, Hamada Y, Katsurahara M, Ninomiya K, Nishikawa K, Nojiri K, Yamada R, Inoue H, Gabazza EC, Katayama N, Takei Y (2015) Second and third-look endoscopy for the prevention of post-ESD bleeding. J Infect Chemother 21:444–448
Kagawa T, Iwamuro M, Ishikawa S, Ishida M, Kuraoka S, Sasaki K, Sakakihara I, Izumikawa K, Yamamoto K, Takahashi S, Tanaka, Matsuura M, Hasui T, Wato M, Inaba T (2016) Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers. Aliment Pharmacol Ther 44:583–591
Tsuji Y, Fujishiro M, Kodashima S, Ono S, Niimi K, Mochizuki S, Asada-Hirayama I, Matsuda R, Minsatsuki C, Nakayama C, Takahashi Y, Sakaguchi Y, Yamamichi N, Koike K (2015) Polyglycolic acid sheets and fibrin glue decrease the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms (with video). Gastrointest Endosc 81:906–912
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Takafumi Yano, Satoshi Tanabe, Kenji Ishido, Mizuto Suzuki, Natsuko Kawanishi, Sakiko Yamane, Akinori Watanabe, Takuya Wada, Mizutomo Azuma, Chikatoshi Katada and Wasaburo Koizumi declares that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Yano, T., Tanabe, S., Ishido, K. et al. Different clinical characteristics associated with acute bleeding and delayed bleeding after endoscopic submucosal dissection in patients with early gastric cancer. Surg Endosc 31, 4542–4550 (2017). https://doi.org/10.1007/s00464-017-5513-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-017-5513-1